Search Results

Search

Ethics Talk: Health Hazards of Cost Sharing

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Ziad Obermeyer about the potential impact on mortality of cost-sharing practices of health insurers.

Click here to read the transcript. 

Ziad Obermeyer, MD, MPhil is the Blue Cross of California Distinguished Associate Professor of Health Policy and Management, UC Berkeley School of Public Health.

Video

Recorded on March 9, 2021

 

Audio

 

Conflict of Interest Disclosure
Interviewee reports having equity stakes in Deep Health Dandelion Health and Berkeley Data Ventures as well as receiving speaking and consulting fees from Independence Blue Cross and Anthem.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Racial and Ethnic Health Equity in the US: Part 2 CME Off
Medical Education
Aug 2016

Improving Pathologists’ Communication Skills

Suzanne Dintzis, MD, PhD
The communication training program at University of Washington Medical Center aims to develop best practices for effective pathology communication.
AMA J Ethics. 2016; 18(8):802-808. doi: 10.1001/journalofethics.2016.18.8.medu1-1608.
Case and Commentary
Feb 2019

How Should AI Be Developed, Validated, and Implemented in Patient Care?

Michael Anderson, PhD and Susan Leigh Anderson, PhD
Two concerns (unknowability of how output is derived from input and overreliance on clinical decision support systems) are main sources of ethical questions about AI in health care.
AMA J Ethics. 2019; 21(2):E125-130. doi: 10.1001/amajethics.2019.125.
In the Literature
Apr 2016

A Defense of “The Case for Conserving Disability”

Jasmine Zahid
Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit.
AMA J Ethics. 2016; 18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604.
Case and Commentary
Aug 2020

Is Nonconsensual Tapering of High-Dose Opioid Therapy Justifiable?

Travis N. Rieder, PhD
Legacy patients are so-called because their opioid use behaviors express past, aggressive opioid prescribing by a clinician. Managing their pain and dependence justly is ethically complex.
AMA J Ethics. 2020; 22(8):E651-657. doi: 10.1001/amajethics.2020.651.
Policy Forum
Aug 2020

Revisiting the WHO Analgesic Ladder for Surgical Management of Pain

Laura Stone McGuire, MD and Konstantin Slavin, MD
A 3-step analgesic ladder was introduced in 1986 and needs change. Surgical interventions could reduce opioid use and motivate expansion of current pain management approaches.
AMA J Ethics. 2020; 22(8):E695-701. doi: 10.1001/amajethics.2020.695.
Medical Education
May 2022

What Should Clinicians Know About Dietary Supplement Quality?

Marissa Chaet Brykman, JD, Virginia Streusand Goldman, PhD, Nandakumara Sarma, PhD, RPh, Hellen A. Oketch-Rabah, PhD, MSc, Deborah Biswas, JD, and Gabriel I. Giancaspro, PhD
Increase in dietary supplement use in the United States suggests a great need for clinicians to be aware of the range of their quality parameters.
AMA J Ethics. 2022; 24(5):E382-389. doi: 10.1001/amajethics.2022.382.